Metraipolis › archive › dc_8d16383efcb7

Nanobodies targeting SARS-CoV-2 variants — Europe PMC PMID:42592525

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42592525
DOI
10.1016/j.apsb.2026.06.017
License (as archived)
solo-consultazione
Archived
2026-10-31T13:04:35.756Z
SHA-256 of the archived text
efcadb33d9c985f1c2bead00ba4ddb595b1a5109be882a0ae4bdea8bc8a405f5
Stable URL of this page
https://metraipolis.com/documento/dc_8d16383efcb7

How to cite

Nanobodies targeting SARS-CoV-2 variants — Europe PMC PMID:42592525 — Europe PMC (en), https://europepmc.org/article/MED/42592525 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d16383efcb7 (Metraipolis archive dc_8d16383efcb7, sha256 efcadb33d9c985f1c2bead00ba4ddb595b1a5109be882a0ae4bdea8bc8a405f5)
BibTeX
@misc{dc8d16383efcb7,
  title = {Nanobodies targeting SARS-CoV-2 variants — Europe PMC PMID:42592525},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42592525},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d16383efcb7; sha256 efcadb33d9c985f1c2bead00ba4ddb595b1a5109be882a0ae4bdea8bc8a405f5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42592525. Agents can read the archived copy with the MCP tool read_document.